August 1st 2025
This article presents a systematic review of US health care disparities in biologics access across immunology (ie, rheumatology, dermatology, and gastroenterology) and a call to action.
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
View More
Leveraging Biologics and Immunotherapies in the Management of Food Allergies
1.5 Credits / Immunology, Allergy
View More
Reflecting on the Real-World Use of Biologic Therapy in Asthma Management
1.5 Credits / Immunology, Pulmonology
View More
Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden
1.5 Credits / Immunology
View More
Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition
1.5 Credits / Gastroenterology, Immunology
View More
Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches
1.5 Credits / Gastroenterology, Immunology
View More
The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care
1.0 Credit / Immunology, Nephrology
View More
The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes
1.0 Credit / Immunology, Nephrology
View More
Payment for Pharmacist Services: 2025 Update
1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law
View More
From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape
1.0 Credit / Immunology, Rare Diseases
View More
Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape
1.0 Credits / Dermatology, Immunology
View More
Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes
2.0 Credits / Immunology, Rare Diseases, Hematology
View More
Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models
1.0 Credit / Immunology, Neurology, Rare Diseases
View More
IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems
1.0 Credits / Dermatology, Immunology
View More
The Expanding Therapeutic Landscape in IgA Nephropathy: Translating New Clinical Evidence and Updated Guidelines Into Managed Care Strategies
1.0 Credit / Immunology, Nephrology
View More
Standard Uptake Value Index May Aid in Diagnosis of Polymyalgia Rheumatica
August 8th 2023Polymyalgia rheumatica (PMR) is an inflammatory disease often misdiagnosed as certain cancers, among other diseases. Researchers have recently made progress to better diagnose PMR using a standard uptake value index based on fluorodeoxyglucose with positron-emission tomography/computed tomography.
Read More
Perceived Necessity vs Implementation of Psychological Support for Patients With RA in Japan
July 22nd 2023Patient-centered care (PCC) is a major part of a patient’s daily life that addresses their psychological needs, among other needs and preferences. Quality PCC has been recognized as important in clinical practice; however, implementation rates remain comparatively low.
Read More
ePROM Monitoring of Patients With Inflammatory Arthritides May Be Beneficial, Review Suggests
July 15th 2023Utilizing electronic patient-reported outcome measures (ePROMs) may hold potential to reduce health care resource utilization without affecting outcomes for patients with inflammatory arthritides, such as rheumatoid arthritis.
Read More
Certain Gut Bacteria May Promote Disease Activity in Patients With Lupus Nephritis
July 13th 2023A study suggests that strains of ruminococcus (blautia) gnavus (RG) seen in the gut microbiome of patients in active lupus nephritis might be drivers of disease flares and highlight the possible pathogenic qualities of specific strains.
Read More
Disease Activity–Guided Dosing Safe, Effective for Up to 10 Years in Rheumatoid Arthritis
July 7th 2023Noortje van Herwaarden, MD, PhD, discusses the results of a 10-year follow-up from the DRESS study and how it informs use of disease activity-guided dose optimization in treatment of rheumatoid arthritis.
Read More
Multimorbidity May Increase Risk, Duration of Hospitalization for Patients With RA
December 2nd 2022With 60% to 75% of patients with rheumatoid arthritis (RA) developing other long-term conditions throughout their lifetime, the researchers underscored the importance of using multimorbidity in risk stratification of patients with RA based on their findings.
Read More
Systematic Review Highlights Inconsistent Evidence on Role of Diet in RA Risk
December 2nd 2022Generally, the studies suggested a decreased risk of rheumatoid arthritis (RA) associated with fish and vegetable consumption, as well as Mediterranean-style diets, although the researchers noted that these studies used varying methods and had varying results.
Read More